Detalhe da pesquisa
1.
A Glutamate N-Methyl-d-Aspartate (NMDA) Receptor Subunit 2B-Selective Inhibitor of NMDA Receptor Function with Enhanced Potency at Acidic pH and Oral Bioavailability for Clinical Use.
J Pharmacol Exp Ther
; 379(1): 41-52, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34493631
2.
Synthesis and Antiviral Activity of a Series of 2'-C-Methyl-4'-thionucleoside Monophosphate Prodrugs.
Molecules
; 25(21)2020 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33171951
3.
Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 Mpro Inhibitors.
ACS Med Chem Lett
; 14(10): 1434-1440, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37849558
4.
Accelerated Discovery of Novel Ponatinib Analogs with Improved Properties for the Treatment of Parkinson's Disease.
ACS Med Chem Lett
; 11(4): 491-496, 2020 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32292555
5.
Correction to "Accelerated Discovery of Novel Ponatinib Analogs with Improved Properties for the Treatment of Parkinson's Disease".
ACS Med Chem Lett
; 11(7): 1491, 2020 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676160
6.
Accelerated Discovery of Potent Fusion Inhibitors for Respiratory Syncytial Virus.
ACS Infect Dis
; 6(5): 922-929, 2020 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275393
7.
Design and Validation of FRESH, a Drug Discovery Paradigm Resting on Robust Chemical Synthesis.
ACS Med Chem Lett
; 6(5): 518-22, 2015 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26005525